Article: XIEHE GROUP SETS UP SHENZHEN GENETIC ENGINEERING SUBSIDIARY


AsiaInfo Services
08-11-2008
Xiehe Group Sets Up Shenzhen Genetic Engineering Subsidiary

SHENZHEN, Aug 11, 2008 (SinoCast via COMTEX) -- Chinese pharmaceutical producer Shenyang Xiehe Group Co., Ltd. yesterday established a wholly-owned genetic engineering subsidiary in Shenzhen, a boomtown neighboring Hong Kong.

The company intends to shift R&D of antitumor drugs and drugs for prevention and treatment of leukemia, one of its key works, to Shenzhen, said its chairman Chen Juyu. And it plans to locate its R&D base and international sales base, which would help the company in overseas expansion, in the city.

Based in Shenyang City, Liaoning Province, Northeast China, Xiehe Group is ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!